Combined Placental Maternal Floor Infarction and Cytomegalovirus Placentitis: A Case Report

Combined Placental Maternal Floor Infarction and Cytomegalovirus Placentitis: A Case Report

Mother’s infarction (MFI) and Masif Fibrin Perive (MPFD) deposition (MPFD) are unusual, related to the condition of the secondary placenta of trophoblastic cell damage. The etiology is unknown but MPFD / MFI is associated with adverse obstetric results and a significant risk of repeatment. Case Report: We report the MPFD / MFI case related to placentitis Cytomegalovirus (CMV). A 27-year-old mother gave birth to a man’s fetus born with a postmortem diagnosis of default CMV.

The placenta shows limfohistiocial villitis with isolated CMV inclusion, in combination with MFI. Villitis has an intermediary feature between unclean cmv placentitis and ethiological villitis (Vue). Conclusion: Vue is considered a reaction of an anti-fetal immune mother who resembles the refusal of allograft. We postulate that viral infections in our case may have triggered this immune response, considering that CMV antigens are known to be crossing with some human antigens, especially HLA. The next trophoblastic cell damage can then lead to MFI / MFPD.

Hemolytic uremic syndrome and atypical nephrotic syndrome associated with cytomegalovirus infection

Atypical hemolytic uremic syndrome (ahus) is a rare disease. It is produced from the disregulation of alternative complementary pathways on the cell surface which causes endothelial damage. Increasing evidence evidence, this disorder is for mutations in the complementary regulator gene or with autoantibodies to complementary factors. This mutation has incomplete penetration and variable phenotypes.

Cytomegalovirus (CMV) is endemic throughout the world, and the incidence of severe CMV disease in immunocompetent adults seems to be greater than previously thought. Ahus and nephrotic syndrome associated with CMV infection rarely occur. The identification of triggers for the manifestation of the ahus in patients who are vulnerable genetics is very important because this allows faster clinical treatment and improvement initiations. We reported a case of a man with the removal of homozygous CFHR3-1 whose initial presentation was ahus and nephrotic syndrome associated with CMV infection.

IgA binds epitop glycoprotein B and neutralizes human cytomegalovirus

Human Cytomegalovirus (HCMV) is a pathogen everywhere that has the potential for pathogens in immunosuppression individuals and pregnant women during primary infections. HCMV Envelope Glycoprotein B (GB) facilitates virus entries into all types of cells and induces strong immune responses. Epitope AD-2 is a very preserved GB Linear GB epitope and the critical target for antibodies, only 50% of seropositive individuals that make IgG antibodies to this site and the rib response has not been fully investigated.

This study aims to compare IGG and IGA responses to GB and Epitop AD-2 in individuals who are exposed to naturally and those who receive the recombinant Ajuvant GB / MF59 vaccine. Thus, seropositive individual vaccination increases the existing IGA and GB IGG levels and induces the rib response and specific IGG de Novo GB on seronegative receivers. The existing IgG response and AD-2 ribs were driven by vaccination but the response of De Novo AD-2 was not detected. Individuals exposed naturally have the dominant IgG response to GB and AD-2 compared to weaker rib responses and variables, although significant rib response to AD-2 was observed in the ASI ASI sample.

All antibodies tie the AD-2 contain a light chain of kappa while the use of a balanced capa / lambda light chain is found for those who bind to GB. The V-region matches the specific recombinant IGG AD-2 and ribs are bound to GB and AD-2 and neutralize HCMV infection in vitro. Overall, this result shows that even though the human IGG response dominates, class IGA antibodies against AD-2 are significant components of breast milk that can function to protect neonates from HCMV.

Cytomegalovirus After a kidney transplant in 2020: moving towards personalized prevention

Cytomegalovirus (CMV) – Close complications after kidney transplants remain a substantial challenge. Instead of applying a preventive strategy to all risky patients, we can now adjust our strategies at the individual patient level. The prophylaxis of antivirus or strict pre-emptive strategies may be optimal for patients with the highest risk for CMV, while lower risk patients can be profitable especially from pre-emptive monitoring and therapeutic administration only if needed.

CMV Special T-Testing may be useful to improve the determination of CMV risk in pre-transplants, and to guide decisions about the need for antivirus therapy or duration. Immunosupressive regimens including the target of the Rapamycin mammal inhibitor reduces the risk of CMV and thus can be an interesting choice in some patients. The new antivirus agent further expanded our therapy arsenal in the near future, and the prospect of CMV vaccination and remove cell therapy seems to be on the horizon.

Combined Placental Maternal Floor Infarction and Cytomegalovirus Placentitis: A Case Report

Cytomegalovirus Pre-Transplant Immunity and Risk of Viral Reactivation After Lung Transplantation: Prospective Cohort Study

Cytomegalovirus (CMV) remains a significant burden on the recipient of the lung transplant. Disadvantages in the immunity of the TP-transplant increases the risk of complications related to CMV. However, it is not clear if the underlying pre-transplant immunity increases risk. To assess this, we recruit 39 lung transplant patients and do quantiferon-CMV in their peripheral blood. More than a third of prospective cmv-seropositive transplant receivers are non-imun-reactive CMV (CMV-NIR) pre-transplant.

Hba Polyclonal Antibody

A53679
  • EUR 684.66
  • Ask for price
  • Ask for price
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

HBA Polyclonal Antibody

ES11261-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

HBA Polyclonal Antibody

ES11261-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Human Brain Astrocytes (HBA)

HMP202 500,000+ cells - Frozen
EUR 1296

Hba Antibody, HRP conjugated

1-CSB-PA010147LB01MO
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA

Hba Antibody, FITC conjugated

1-CSB-PA010147LC01MO
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA

Hba Antibody, Biotin conjugated

1-CSB-PA010147LD01MO
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA

Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K6915803 1.0 ug DNA
EUR 184.8

Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3266403 1.0 ug DNA
EUR 184.8

Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3179403 1.0 ug DNA
EUR 184.8

Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3332403 1.0 ug DNA
EUR 184.8

HBA ELISA Kit (Mouse) (OKEH05810)

OKEH05810 96 Wells
EUR 794.4
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues. ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.84 ng/mL

HBA ELISA Kit (Bovine) (OKEH03848)

OKEH03848 96 Wells
EUR 934.8
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues.;Species reactivity: Bovine;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.59 ng/mL

Hba-a2 Recombinant Protein (Rat)

RP204248 100 ug Ask for price

Hba-x Recombinant Protein (Mouse)

RP140996 100 ug Ask for price

Mouse Hemoglobin subunit alpha (Hba)

1-CSB-YP010147MO
  • EUR 604.80
  • EUR 318.00
  • EUR 2198.40
  • EUR 915.60
  • EUR 1459.20
  • EUR 400.80
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in Yeast

Mouse Hemoglobin subunit alpha (Hba)

1-CSB-EP010147MO
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in E.coli

Hba-a1 Recombinant Protein (Mouse)

RP140990 100 ug Ask for price

Hba-a2 Recombinant Protein (Mouse)

RP140993 100 ug Ask for price

Hemoglobin Subunit Alpha (Hba) Antibody

20-abx109857
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Hba Polyclonal Antibody, HRP Conjugated

A53680
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Hba Polyclonal Antibody, FITC Conjugated

A53681
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Hba Polyclonal Antibody, Biotin Conjugated

A53682
  • EUR 684.66
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 50 ul
  • 100 ul

Rat Hemoglobin subunit alpha-1/2, HBA ELISA Kit

ELA-E0517r 96 Tests
EUR 1063.2

Hba-a2 ORF Vector (Rat) (pORF)

ORF068084 1.0 ug DNA
EUR 607.2

Hba-x ORF Vector (Mouse) (pORF)

ORF047000 1.0 ug DNA
EUR 607.2

Hba-a1 ORF Vector (Mouse) (pORF)

ORF046998 1.0 ug DNA
EUR 607.2

Hba-a2 ORF Vector (Mouse) (pORF)

ORF046999 1.0 ug DNA
EUR 607.2

Hba-a2 sgRNA CRISPR Lentivector set (Rat)

K6915801 3 x 1.0 ug
EUR 406.8

Hba-x sgRNA CRISPR Lentivector set (Mouse)

K3266401 3 x 1.0 ug
EUR 406.8

Hba-a2 sgRNA CRISPR Lentivector set (Mouse)

K3179401 3 x 1.0 ug
EUR 406.8

Hba-a1 sgRNA CRISPR Lentivector set (Mouse)

K3332401 3 x 1.0 ug
EUR 406.8

Human Hemoglobin subunit alpha, HBA ELISA Kit

ELA-E05171h 96 Tests
EUR 988.8

Mouse Hemoglobin subunit alpha, HBA ELISA Kit

ELA-E0517m 96 Tests
EUR 1038

Mouse Hemoglobin subunit alpha(HBA)ELISA Kit

YLA1329MO-48T 48T
EUR 465

Mouse Hemoglobin subunit alpha(HBA)ELISA Kit

YLA1329MO-96T 96T
EUR 600

Bovine HBA/ Hemoglobin subunit alpha ELISA Kit

E0304Bo 1 Kit
EUR 860.4

Bovine Hemoglobin subunit alpha, HBA ELISA Kit

ELA-E0517b 96 Tests
EUR 1113.6

Canine Hemoglobin subunit alpha, HBA ELISA Kit

ELA-E0517d 96 Tests
EUR 1113.6

Canine Hemoglobin subunit alpha(HBA)ELISA Kit

YLA0127CA-48T 48T
EUR 502.5

Canine Hemoglobin subunit alpha(HBA)ELISA Kit

YLA0127CA-96T 96T
EUR 618.75

Bovine Hemoglobin subunit alpha(HBA)ELISA Kit

YLA0005BO-48T 48T
EUR 502.5

Bovine Hemoglobin subunit alpha(HBA)ELISA Kit

YLA0005BO-96T 96T
EUR 618.75

Chicken Hemoglobin subunit alpha, HBA ELISA Kit

ELA-E0517c 96 Tests
EUR 1113.6

Porcine Hemoglobin subunit alpha, HBA ELISA Kit

ELA-E0517p 96 Tests
EUR 1113.6

Porcine Hemoglobin subunit alpha(HBA)ELISA Kit

YLA0356PO-48T 48T
EUR 502.5

Porcine Hemoglobin subunit alpha(HBA)ELISA Kit

YLA0356PO-96T 96T
EUR 618.75

Hba-x 3'UTR GFP Stable Cell Line

TU159377 1.0 ml Ask for price

Hba-a1 3'UTR GFP Stable Cell Line

TU159375 1.0 ml Ask for price

Hba-a2 3'UTR GFP Stable Cell Line

TU159376 1.0 ml Ask for price

Hba-a2 3'UTR GFP Stable Cell Line

TU255653 1.0 ml Ask for price

Hba-a2 Protein Vector (Rat) (pPM-C-HA)

PV272336 500 ng
EUR 723.6

Hba-x Protein Vector (Mouse) (pPM-C-HA)

PV188000 500 ng
EUR 723.6

Hba-a2 Protein Vector (Rat) (pPB-C-His)

PV272334 500 ng
EUR 723.6

Hba-a2 Protein Vector (Rat) (pPB-N-His)

PV272335 500 ng
EUR 723.6

Hba-a2 Protein Vector (Rat) (pPM-C-His)

PV272337 500 ng
EUR 723.6

Hba-a1 Protein Vector (Mouse) (pPM-C-HA)

PV187992 500 ng
EUR 723.6

Hba-a2 Protein Vector (Mouse) (pPM-C-HA)

PV187996 500 ng
EUR 723.6

Hba-x Protein Vector (Mouse) (pPB-C-His)

PV187998 500 ng
EUR 723.6

Hba-x Protein Vector (Mouse) (pPB-N-His)

PV187999 500 ng
EUR 723.6

Hba-x Protein Vector (Mouse) (pPM-C-His)

PV188001 500 ng
EUR 723.6

Hba-x 3'UTR Luciferase Stable Cell Line

TU109377 1.0 ml Ask for price

Hba-a1 Protein Vector (Mouse) (pPB-C-His)

PV187990 500 ng
EUR 723.6

Hba-a1 Protein Vector (Mouse) (pPB-N-His)

PV187991 500 ng
EUR 723.6

Hba-a1 Protein Vector (Mouse) (pPM-C-His)

PV187993 500 ng
EUR 723.6

Hba-a2 Protein Vector (Mouse) (pPB-C-His)

PV187994 500 ng
EUR 723.6

Hba-a2 Protein Vector (Mouse) (pPB-N-His)

PV187995 500 ng
EUR 723.6

Hba-a2 Protein Vector (Mouse) (pPM-C-His)

PV187997 500 ng
EUR 723.6

Hba-a1 3'UTR Luciferase Stable Cell Line

TU109375 1.0 ml Ask for price

Hba-a2 3'UTR Luciferase Stable Cell Line

TU109376 1.0 ml Ask for price

Hba-a2 3'UTR Luciferase Stable Cell Line

TU205653 1.0 ml Ask for price

Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K6915802 1.0 ug DNA
EUR 184.8

Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K6915804 1.0 ug DNA
EUR 184.8

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6915807 1.0 ug DNA
EUR 200.4

Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3266402 1.0 ug DNA
EUR 184.8

Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3266404 1.0 ug DNA
EUR 184.8

Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3266407 1.0 ug DNA
EUR 200.4

Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3179402 1.0 ug DNA
EUR 184.8

Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3179404 1.0 ug DNA
EUR 184.8

Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3332402 1.0 ug DNA
EUR 184.8

Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3332404 1.0 ug DNA
EUR 184.8

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3179407 1.0 ug DNA
EUR 200.4

Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3332407 1.0 ug DNA
EUR 200.4

Anti-HBA antibody

STJ192419 200 µl
EUR 236.4
Description: Unconjugated Rabbit polyclonal to HBA

Hba-a2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV678205 1.0 ug DNA
EUR 616.8

Hba-a2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV678209 1.0 ug DNA
EUR 616.8

Hba-a2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV678210 1.0 ug DNA
EUR 616.8

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6915805 3 x 1.0 ug
EUR 451.2

Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3266405 3 x 1.0 ug
EUR 451.2

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3179405 3 x 1.0 ug
EUR 451.2

Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3332405 3 x 1.0 ug
EUR 451.2

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6915806 1.0 ug DNA
EUR 200.4

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6915808 1.0 ug DNA
EUR 200.4

Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3266406 1.0 ug DNA
EUR 200.4

Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3266408 1.0 ug DNA
EUR 200.4

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3179406 1.0 ug DNA
EUR 200.4

Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3179408 1.0 ug DNA
EUR 200.4

Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3332406 1.0 ug DNA
EUR 200.4

Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3332408 1.0 ug DNA
EUR 200.4

Hba-a2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV678206 1.0 ug DNA
EUR 616.8

Hba-a2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV678207 1.0 ug DNA
EUR 686.4

Hba-a2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV678208 1.0 ug DNA
EUR 686.4

Hemoglobin subunit alpha Antibody / HBA1/2

RQ6772 100ug
EUR 356.15
Description: The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported.

Human Hemoglobin Alpha 2(HBa2)ELISA Kit

QY-E00676 96T
EUR 433.2

HBA1 sgRNA CRISPR Lentivector (Human) (Target 2)

K0931303 1.0 ug DNA
EUR 184.8

HBA2 sgRNA CRISPR Lentivector (Human) (Target 2)

K0931403 1.0 ug DNA
EUR 184.8

HBA2 Hemoglobin, Alpha 2 Human Recombinant Protein

PROTP69905 Regular: 20ug
EUR 380.4
Description: HBA2 Human Recombinant produced in E. coli is a single polypeptide chain containing 179 amino acids (1-142) and having a molecular mass of 19.5 kDa.;HBA2 is fused to a 37 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Rat Hemoglobin Subunit Alpha 1/2 (HBA1) ELISA Kit

abx256288-96tests 96 tests
EUR 801.6

Rat Hba1/ Hemoglobin subunit alpha-1/2 ELISA Kit

E0438Ra 1 Kit
EUR 685.2

Rat Hemoglobin subunit alpha-1/2(HBA1)ELISA Kit

YLA1171RA-48T 48T
EUR 465

Rat Hemoglobin subunit alpha-1/2(HBA1)ELISA Kit

YLA1171RA-96T 96T
EUR 600

The CMV-NIR status is associated with the incidence of CMV reactivation transplantation which is significantly higher, indicating that the immunity of CMV dysfunctional in prospective lung transplant recipients is associated with an increased risk of viral viral-transplant reactivation.
Keywords: cytomegalovirus; T-cell immunity; solid organ transplant; Virus reactivation.

Leave A Comment